Literature DB >> 25266986

The mammalian Hippo pathway: regulation and function of YAP1 and TAZ.

Manami Kodaka1, Yutaka Hata.   

Abstract

The Hippo pathway was originally identified as the signaling that controls organ size in Drosophila, with the core architecture conserved in mammals. In the mammalian Hippo pathway, mammalian Ste20-like kinases (MST1/2) and large tumor suppressor kinases (LATS1/2) regulate transcriptional co-activators, Yes-associated protein (YAP1) and Transcriptional co-activator with a PDZ-binding motif (TAZ). The Hippo pathway was initially thought to be quite straightforward; however, the identification of additional components has revealed its inherent complexity. Regulation of YAP1 and TAZ is not always dependent on MST1/2 and LATS1/2. MST1/2 and LATS1/2 play various YAP1/TAZ-independent roles, while YAP1 and TAZ cross-talk with other signaling pathways. In this review we focus on YAP1 and TAZ and discuss their regulation, function, and the consequences of their dysregulation.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25266986     DOI: 10.1007/s00018-014-1742-9

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  242 in total

1.  Switch enhancers interpret TGF-β and Hippo signaling to control cell fate in human embryonic stem cells.

Authors:  Tobias A Beyer; Alexander Weiss; Yuliya Khomchuk; Kui Huang; Abiodun A Ogunjimi; Xaralabos Varelas; Jeffrey L Wrana
Journal:  Cell Rep       Date:  2013-12-12       Impact factor: 9.423

2.  Hippo signaling regulates microprocessor and links cell-density-dependent miRNA biogenesis to cancer.

Authors:  Masaki Mori; Robinson Triboulet; Morvarid Mohseni; Karin Schlegelmilch; Kriti Shrestha; Fernando D Camargo; Richard I Gregory
Journal:  Cell       Date:  2014-02-27       Impact factor: 41.582

3.  Hippo pathway activity influences liver cell fate.

Authors:  Dean Yimlamai; Constantina Christodoulou; Giorgio G Galli; Kilangsungla Yanger; Brian Pepe-Mooney; Basanta Gurung; Kriti Shrestha; Patrick Cahan; Ben Z Stanger; Fernando D Camargo
Journal:  Cell       Date:  2014-06-05       Impact factor: 41.582

4.  A novel acetylation cycle of transcription co-activator Yes-associated protein that is downstream of Hippo pathway is triggered in response to SN2 alkylating agents.

Authors:  Shoji Hata; Jun Hirayama; Hiroaki Kajiho; Kentaro Nakagawa; Yutaka Hata; Toshiaki Katada; Makoto Furutani-Seiki; Hiroshi Nishina
Journal:  J Biol Chem       Date:  2012-04-27       Impact factor: 5.157

5.  Regulation of insulin-like growth factor signaling by Yap governs cardiomyocyte proliferation and embryonic heart size.

Authors:  Mei Xin; Yuri Kim; Lillian B Sutherland; Xiaoxia Qi; John McAnally; Robert J Schwartz; James A Richardson; Rhonda Bassel-Duby; Eric N Olson
Journal:  Sci Signal       Date:  2011-10-25       Impact factor: 8.192

6.  Structural insights into the YAP and TEAD complex.

Authors:  Ze Li; Bin Zhao; Ping Wang; Fei Chen; Zhenghong Dong; Huirong Yang; Kun-Liang Guan; Yanhui Xu
Journal:  Genes Dev       Date:  2010-02-01       Impact factor: 11.361

7.  Role of the tumor suppressor RASSF2 in regulation of MST1 kinase activity.

Authors:  Hoogeun Song; Sangphil Oh; Hyun Jung Oh; Dae-Sik Lim
Journal:  Biochem Biophys Res Commun       Date:  2009-12-04       Impact factor: 3.575

8.  Tumor suppressor Nf2 limits expansion of the neural progenitor pool by inhibiting Yap/Taz transcriptional coactivators.

Authors:  Alfonso Lavado; Yu He; Joshua Paré; Geoffrey Neale; Eric N Olson; Marco Giovannini; Xinwei Cao
Journal:  Development       Date:  2013-07-17       Impact factor: 6.868

9.  Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene.

Authors:  Dawang Zhou; Claudius Conrad; Fan Xia; Ji-Sun Park; Bernhard Payer; Yi Yin; Gregory Y Lauwers; Wolfgang Thasler; Jeannie T Lee; Joseph Avruch; Nabeel Bardeesy
Journal:  Cancer Cell       Date:  2009-11-06       Impact factor: 31.743

10.  Mammalian Tead proteins regulate cell proliferation and contact inhibition as transcriptional mediators of Hippo signaling.

Authors:  Mitsunori Ota; Hiroshi Sasaki
Journal:  Development       Date:  2008-11-12       Impact factor: 6.868

View more
  42 in total

1.  YAP promotes epithelial mesenchymal transition by upregulating Slug expression in human colorectal cancer cells.

Authors:  Dan Cheng; Lan Jin; Yunhe Chen; Xueyan Xi; Yang Guo
Journal:  Int J Clin Exp Pathol       Date:  2020-04-01

Review 2.  YAP and the Hippo pathway in pediatric cancer.

Authors:  Atif A Ahmed; Abdalla D Mohamed; Melissa Gener; Weijie Li; Eugenio Taboada
Journal:  Mol Cell Oncol       Date:  2017-02-25

3.  The novel potent TEAD inhibitor, K-975, inhibits YAP1/TAZ-TEAD protein-protein interactions and exerts an anti-tumor effect on malignant pleural mesothelioma.

Authors:  Ayumi Kaneda; Toshihiro Seike; Tomohiro Danjo; Takahiro Nakajima; Nobumasa Otsubo; Daisuke Yamaguchi; Yoshiro Tsuji; Kaori Hamaguchi; Mai Yasunaga; Yoichi Nishiya; Michihiko Suzuki; Jun-Ichi Saito; Rie Yatsunami; Satoshi Nakamura; Yoshitaka Sekido; Kiyotoshi Mori
Journal:  Am J Cancer Res       Date:  2020-12-01       Impact factor: 6.166

4.  H-ras Inhibits the Hippo Pathway by Promoting Mst1/Mst2 Heterodimerization.

Authors:  Sonali J Rawat; Daniela Araiza-Olivera; Luis E Arias-Romero; Olga Villamar-Cruz; Tatiana Y Prudnikova; Heinrich Roder; Jonathan Chernoff
Journal:  Curr Biol       Date:  2016-05-26       Impact factor: 10.834

5.  The YAP1 Signaling Inhibitors, Verteporfin and CA3, Suppress the Mesothelioma Cancer Stem Cell Phenotype.

Authors:  Sivaveera Kandasamy; Gautam Adhikary; Ellen A Rorke; Joseph S Friedberg; McKayla B Mickle; H Richard Alexander; Richard L Eckert
Journal:  Mol Cancer Res       Date:  2019-11-15       Impact factor: 5.852

6.  A role for the transducer of the Hippo pathway, TAZ, in the development of aggressive types of endometrial cancer.

Authors:  Laura Romero-Pérez; Pablo Garcia-Sanz; Alba Mota; Susanna Leskelä; Marta Hergueta-Redondo; Juan Díaz-Martín; M Angeles López-García; M Angeles Castilla; Angel Martínez-Ramírez; Robert A Soslow; Xavier Matias-Guiu; Gema Moreno-Bueno; Jose Palacios
Journal:  Mod Pathol       Date:  2015-09-18       Impact factor: 7.842

7.  Yap1 is required for maintenance of adult RPE differentiation.

Authors:  Qingxian Lu; Patrick A Scott; Eric V Vukmanic; Henry J Kaplan; Douglas C Dean; Qiutang Li
Journal:  FASEB J       Date:  2020-03-29       Impact factor: 5.191

8.  Phosphorylation of Tyr188 in the WW domain of YAP1 plays an essential role in YAP1-induced cellular transformation.

Authors:  Ying-Wei Li; Jin Guo; He Shen; Jun Li; Nuo Yang; Costa Frangou; Kayla E Wilson; Yinglong Zhang; Ashley L Mussell; Marius Sudol; Amjad Farooq; Jun Qu; Jianmin Zhang
Journal:  Cell Cycle       Date:  2016-07-18       Impact factor: 4.534

9.  The RASSF6 Tumor Suppressor Protein Regulates Apoptosis and Cell Cycle Progression via Retinoblastoma Protein.

Authors:  Shakhawoat Hossain; Hiroaki Iwasa; Aradhan Sarkar; Junichi Maruyama; Kyoko Arimoto-Matsuzaki; Yutaka Hata
Journal:  Mol Cell Biol       Date:  2018-08-15       Impact factor: 4.272

10.  Loss of Apc Cooperates with Activated Oncogenes to Induce Liver Tumor Formation in Mice.

Authors:  Yi Zhang; Binyong Liang; Xinhua Song; Haichuan Wang; Matthias Evert; Yi Zhou; Diego F Calvisi; Liling Tang; Xin Chen
Journal:  Am J Pathol       Date:  2021-02-03       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.